ReviewFrontiers in microbiology2026
Polyphenols ameliorate metabolic disorders by remodeling gut microbiota and regulating Nrf2/NF-κB signaling pathways.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intestinal barrier dysfunction, intestinal flora disorder and systemic chronic low-grade inflammation are key pathological processes that drive the progression of a variety of metabolic diseases (including obesity, type 2 diabetes and osteoporosis). Natural polyphenols have the ability to regulate intestinal microecology and regulate multi-target signal transduction, so they show significant metabolic regulation potential in dietary intervention strategies. In view of this, this review takes the pig model (which is highly similar to humans in terms of anatomy, physiology, immunology and intestinal microenvironment) as the research object to explore the intervention effect of polyphenols on metabolic diseases and its transformation clinical value. This review first explains the unique advantages and transformation application prospects of pigs as an ideal large animal model for human metabolic research. Subsequently, the system summarized the molecular mechanism of polyphenols to maintain intestinal homeosta by reshaping the core intestinal flora and promoting the production of short-chain fatty acids (SCFAs). In addition, this review also analyzes the regulatory effect of polyphenols in enhancing systemic antioxidant defense by activating the Nrf2/Keap1 pathway and inhibiting the release of pro-inflammatory factors by blocking the TLR4/NF-κB signaling pathway. By integrating the polyphenol intervention effect observed in the pig model and its potential molecular mechanism, this review provides reliable scientific evidence and theoretical reference for the development of dietary intervention strategies based on natural polyphenols and their subsequent clinical transformation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.